ID 204969908 · FY 2017–2024 · 8 years
Subsidiary of სააქციო საზოგადოება ცე-პეი ხემი ფარმაცი იზოტოპი (100.0%)
Limited public information available beyond the Reportal filing.
curated 2026-06-03reportal.ge
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5,318 | 5,556 | 6,118 | 6,955 | 8,093 | 8,185 | 8,547 | 4,631 | -2.0% |
| Total COGS | -3,666 | -3,016 | -3,297 | -3,860 | -4,253 | -4,173 | -4,478 | -2,476 | -5.5% |
| Gross Profit | 1,651 | 2,540 | 2,821 | 3,095 | 3,839 | 4,012 | 4,069 | 2,155 | +3.9% |
| Gross Margin | 31.1% | 45.7% | 46.1% | 44.5% | 47.4% | 49.0% | 47.6% | 46.5% | |
| Total Operating Expenses | -467 | -1,602 | -874 | -995 | -1,280 | -1,094 | -1,714 | -1,697 | +20.2% |
| EBITDA | 1,185 | 938 | 1,947 | 2,100 | 2,560 | 2,919 | 2,355 | 458 | -12.7% |
| EBITDA Margin | 22.3% | 16.9% | 31.8% | 30.2% | 31.6% | 35.7% | 27.6% | 9.9% | |
| Total D&A | -39 | -62 | -107 | -20 | -15 | -31 | -33 | -36 | -1.1% |
| EBIT / Operating Income | 1,145 | 876 | 1,840 | 2,080 | 2,545 | 2,888 | 2,322 | 421 | -13.3% |
| Total Interest Income | 0 | 0 | 0 | 0 | 13 | 0 | 16 | 23 | +20.4% |
| Total Interest Expense | -61 | -47 | -35 | -43 | -25 | -31 | -31 | -65 | +0.7% |
| Total Other Income | -109 | -60 | 67 | 362 | -144 | -977 | 83 | 519 | nmf |
| Profit Before Tax | 975 | 769 | 1,872 | 2,399 | 2,390 | 1,880 | 2,389 | 899 | -1.2% |
| Total Income Tax | 0 | -1 | -9 | -23 | -0 | 0 | 0 | -0 | -30.8% |
| Net Profit / (Loss) | 555 | 740 | 1,838 | 2,316 | 2,338 | 1,833 | 2,389 | 865 | +6.5% |
| Net Margin | 10.4% | 13.3% | 30.1% | 33.3% | 28.9% | 22.4% | 28.0% | 18.7% |
Ownership & directors from companyinfo.ge (public corporate registry).